This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Duke University. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Innovations of Conrad P Hodgkinson
Introduction
Conrad P Hodgkinson is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cellular reprogramming, particularly in cardiac research. With a total of two patents to his name, Hodgkinson's work is paving the way for advancements in regenerative medicine.
Latest Patents
Hodgkinson's latest patents include "Multicistronic miRNA delivery for cardiac reprogramming." This invention provides a method for promoting the reprogramming of cardiac fibroblasts into cardiomyocytes by using an isolated polynucleotide molecule that comprises at least two functional miRNA sequences. The method utilizes a multicistronic expression system to facilitate the transformation of fibroblasts into functional mature cardiomyocytes. Another significant patent is titled "Compositions and methods for cellular reprogramming." This patent discloses compositions that include one or more miRs and an activator of NFκB. It also outlines methods for enhancing cardiomyocyte maturation in cells or subjects, as well as methods for inhibiting or downregulating cardiomyocyte maturation.
Career Highlights
Hodgkinson is affiliated with Duke University, where he conducts research and develops innovative solutions in the field of cellular reprogramming. His work has garnered attention for its potential applications in treating heart diseases and improving cardiac function.
Collaborations
Some of his notable coworkers include Victor J Dzau and Jaewoo Lee, who have collaborated with Hodgkinson on various research projects.
Conclusion
Conrad P Hodgkinson's contributions to the field of cellular reprogramming are significant and impactful. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.